0.80% -0.002

Glucotrack Inc (GCTK)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Glucotrack Inc Stock (GCTK) Company Profile

Glucotrack Inc

Healthcare (1200)

972 (8) 675-7878

301 RT 17 NORTH, RUTHERFORD

Prossima data di guadagno

Ultimi documenti SEC

GCTK's Discussions on Twitter

Confronta GCTK con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
GCTK Glucotrack Inc	0.2486	1.94M	0	-8.74M	-8.25M	-0.32
ISRG Intuitive Surgical Inc	538.55	192.83B	7.87B	2.24B	586.00M	4.25
BDX Becton Dickinson Co	221.98	64.77B	20.18B	1.73B	3.07B	5.51
ALC Alcon Inc	88.23	43.75B	9.76B	1.16B	665.00M	0.72
RMD Resmed Inc	249.33	36.84B	4.81B	1.11B	1.35B	6.16
WST West Pharmaceutical Services Inc	323.32	23.33B	2.88B	499.60M	321.60M	7.41

Glucotrack Inc Borsa (GCTK) Ultime notizie

Glucotrack Inc Azioni (GCTK) Dati Finanziari

Glucotrack Inc (GCTK)

Glucotrack Inc Stock (GCTK) Company Profile

Confronta GCTK con altri titoli

Glucotrack Inc Borsa (GCTK) Ultime notizie

GCTK stock touches 52-week low at $0.23 amid market challenges - Investing.com Australia

GCTK stock touches 52-week low at $0.23 amid market challenges By Investing.com - Investing.com South Africa

Glucotrack enters material agreements following public offering - Investing.com

Glucotrack enters material agreements following public offering By Investing.com - Investing.com UK

Glucotrack announces pricing of $10M public offering - MSN

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.11% - MSN

GlucoTrack Inc. (GCTK) Quarterly 10-Q Report - Quartzy

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt - The Manila Times

GlucoTrack Completes Funding to Enhance Financial Stability - TipRanks

Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD) - The Manila Times

Glucotrack Secures $10M Through Public Offering, Converts $4M Debt to Equity | GCTK Stock News - StockTitan

STXS Stock Drops 5% Despite Strong Buy Ratings from Analysts - GuruFocus.com

Glucotrack announces $10 million public offering By Investing.com - Investing.com Canada

GCTK stock touches 52-week low at $0.42 amid market fluctuations - Investing.com Australia

500: Something went wrong - Investing.com Canada

S&P 500 Tops 6,000; Rumble Shares Slide After Q3 Results - Benzinga

Dow Jumps Over 150 Points; CyberArk Posts Upbeat Earnings - Benzinga

U.S. Stock market: Syros Pharmaceuticals(−86.21%), GlucoTrack(−77.70%) and others among the most volatile stocks during mid day trading - Business Upturn

U.S. Stock market: Syros Pharmaceuticals surges by 680.00% while Spirit Airlines rises by 184.96% in early trading - Business Upturn

US Stocks Mixed; Inflation Rate Increases In October - Benzinga

GlucoTrack prices 7.2M shares at $1.39 in public offering - TipRanks

Glucotrack announces $10 million public offering - Investing.com

Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering - The Manila Times

Fogo de Chão Launches Pro-Athlete 'Meat & Greet” Event Series With National Sports Teams - The Manila Times

Glucotrack (GCTK) Launches $10M Public Offering, Plans Note Conversion Deal | GCTK Stock News - StockTitan

Harvard Bioscience (HBIO) Stock Dips Amid Market Volatility - GuruFocus.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.65% - MSN

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.66% - MSN

AtriCure (ATRC) Stock Surges Over 5% Amid Market Volatility - GuruFocus.com

United States shares lower at close of trade; Dow Jones Industrial Average down 0.67% - MSN

GlucoTrack (NASDAQ:GCTK) to Present Continuous Blood Glucose Monitor at 2024 BioFuture Meeting** - Defense World

Say Goodbye To Finger Pricks! Glucotrack($GCTK)’s Long-Lasting Glucose Monitor Is Here - MSN

GCTKGlucoTrack, Inc. Latest Stock News & Market Updates - StockTitan

GlucoTrack to Unveil Implantable Glucose Monitor at BioFuture - TipRanks

GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE - The Manila Times

GCTK Stock Earnings: GlucoTrack Reported Results for Q1 2024 - MSN

GlucoTrack (NASDAQ:GCTK) Stock Price Down 1.4% – Here’s What Happened - Defense World

Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology - Nasdaq

GlucoTrack Showcases Innovations at Diabetes Tech Meeting - TipRanks

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING - EIN News

Glucotrack shareholders approve pivotal issuance proposal - Investing.com India

Glucotrack shareholders approve pivotal issuance proposal By Investing.com - Investing.com Canada

Hand-held Glucose Meter Market Growth Ourlook – OrbisResearch - Economica

Godolphin Resources Unveils Comprehensive 2024 Annual Report - TipRanks

Globavend Holdings Limited Announces First Half 2024 Unaudited Financial Results - GlobeNewswire

Global Petroleum Expands Australian Exploration - TipRanks

Qwic owner EcoMotion saves cycling gear brand AGU from downfall - Bike Europe

GPT Infraprojects Secures ₹204 Crore Railway Contract - Indiainfoline

Local Winter Classic competitors clash again in SA Oaks final - The Border Watch

Greenlane to distribute new drug detection strips - Investing.com

GyC hits Kenya, South Africa, Mozambique for mega tour - Guardian Nigeria

Glucotrack Inc Azioni (GCTK) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a GCTK